Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Mol Cell Endocrinol ; 416: 27-35, 2015 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-26284494

RESUMEN

Human clinically non-functioning pituitary adenomas (NFAs) account for approximately 40% of diagnosed pituitary tumors. Epigenetic mutations in tumor suppressive genes play an important role in NFA development. Maternally expressed gene 3 (MEG3) is a long non-coding RNA (lncRNA) and we hypothesized that it is a candidate tumor suppressor whose epigenetic silencing is specifically linked to NFA development. In this study, we introduced MEG3 expression into PDFS cells, derived from a human NFA, using both inducible and constitutively active expression systems. MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. In addition, inactivation of p53 completely abolished tumor suppression by MEG3, indicating that MEG3 tumor suppression is mediated by p53. In conclusion, our data support the hypothesis that MEG3 is a lncRNA tumor suppressor in the pituitary and its inactivation contributes to NFA development.


Asunto(s)
Genes Supresores de Tumor , Hipófisis/metabolismo , Neoplasias Hipofisarias/genética , ARN Largo no Codificante/metabolismo , Acetilación , Animales , Puntos de Control del Ciclo Celular , Línea Celular Tumoral , Epigénesis Genética , Femenino , Fase G1 , Xenoinjertos , Humanos , Ratones , Ratones Desnudos , Cultivo Primario de Células , ARN Largo no Codificante/genética , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA